Highlights From the American Transplant Congress 2011
Source: American Transplant Congress 2011*

Slideset Module

In this downloadable slideset, Seth J. Karp, MD, and Flavio Vincenti, MD, provide commentary and analysis on key studies in transplantation from the 2011 American Transplant Congress.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Update colleagues and students on new biomarkers available to predict transplant outcomes
  • Critically evaluate the results of recent clinical studies of immunosuppressive drugs in solid organ recipients
  • Apply new data on strategies to prevent transplant rejection
  • Integrate new data on transplant outcomes in HIV-infected patients

Topics covered include:

  • Biomarkers
  • Immunosuppresive Drugs
  • Preventing Rejection
  • HIV
 

Faculty

  • Seth J. Karp
    MD
    Flavio Vincenti
    MD

Credit Information

  • Release Date:
    June 15, 2011
  • Expiration Date:
    June 14, 2012
  • Physicians:
    maximum of 0.75 AMA PRA Category 1 Credits

Information on this Educational Activity

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty and CCO staff reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

Faculty

Seth J. Karp, MD


Assistant Professor
Department of Surgery
Harvard Medical School
Director, Pancreas Transplantation
Transplant Surgeon
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Seth J. Karp, MD, has no significant financial relationships to disclose.
 

Flavio Vincenti, MD


Professor of Clinical Medicine
Kidney Transplant
University of California, San Francisco
San Francisco, California

Flavio Vincenti, MD, has disclosed that he has received grants for research support from Astellas, Bristol-Myers Squibb, Genzyme, Novartis, and Pfizer.
 

Staff

Taryn O’Loughlin-Gross, PhD


Senior Managing Editor
Clinical Care Options, LLC
Taryn O’Loughlin Gross, PhD, has no significant financial relationships to disclose.
 

Edward King, M.A.


Vice President, Editorial
Clinical Care Options, LLC
Edward King, MA, has no significant financial relationships to disclose.
 

The following planners and managers, Jan Hixon, RN, BSN, MA; Trace Hutchison, PharmD; Julia Kimball, RN, BSN; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM) and Clinical Care Options, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM and Clinical Care Options, LLC. Please refer to the official prescribing information for each product for discussion of approved indication, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

 

Target Audience

This activity is intended for physicians and other healthcare professionals involved in the management of patients who are candidates for or recipients of solid organ or tissue transplantation.


Goal

The goal of this activity is to identify the most clinically significant data from ATC 2011 and apply those data to management strategies for transplant patients.


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Update colleagues and students on new biomarkers available to predict transplant outcomes
  • Critically evaluate the results of recent clinical studies of immunosuppressive drugs in solid organ recipients
  • Apply new data on strategies to prevent transplant rejection
  • Integrate new data on transplant outcomes in HIV-infected patients
 

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education  through the joint sponsorship of Postgraduate Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Postgraduate Institute for Medicine designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

Commercial Support


This program is supported by an educational grant from Bristol-Myers Squibb.

 

Program Medium


This program has been made available online.

 

Site Requirements


  • Internet Explorer 7+, Firefox 3+, Safari 3+, or Chrome
  • JavaScript enabled
  • 1024x768+ screen resolution
  • Adobe Flash Player
 

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 15, 2011, through June 14, 2012:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.